Default company panoramic image

Prevacus, Inc

Spun out of Florida State University, Prevacus is a drug development company focusing on new treatments for concussions.

  • Stage Product In Development
  • Industry Healthcare Services
  • Location Tallahassee, FL, USA
  • Currency USD
  • Founded June 2012
  • Employees 6
  • Website

Company Summary

At Prevacus, our mission is to provide an effective medical solution for the increasingly high-profile crisis of mild Traumatic Brain Injury. . Founded by Dr. Jacob W. VanLandingham in conjunction with the Florida State University College of Medicine, Prevacus, Inc. is headquartered in Tallahassee, Florida with research laboratories and facilities at the Sid Martin Biotechnology Incubator in Alachua, Florida.


  • Photo
    President & Founder

    Dr. VanLandingham is the Director of Research for the Concussion Clinic and the memory Disorder Clinic at Tallahassee Memorial Healthcare. He also leads the research and diagnostics section of the Institute of Sciences at Florida State University(FSU). His primary field of study is focused on the molecular aspects of brain injury and the effects of neurosteriods on recovery following head trauma and stroke.

  • 574ee0fd 7313 469f baca 94502060c063
    Chief Scientific Officer

    Mr. Lewandowski is an entrepreneur with over 37 years of pharmaceutical development experience working with pharmaceutical companies and clinical research organizations in developing small and large molecule drugs. Mike's experiences includes creation of a histopathology company that has since been absorbed into a mid sized CRO, serving as Director of Safety Evaluation of Scios, Inc., and Manager of Toxicology Studies at Genetech.